StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.85−0.06 (-2.06%)

Close on Nov 17, 2026Market cap $28.36MP/E –Yield –

Scynexis operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Scynexis's operating cash flow for the twelve months ending Jun 30, 2026 was -$13.31M. For fiscal 2025 it was -$5.28M. The highest annual figure on record is $60.16M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$5.28M–
FY2024Dec 31, 2024-$24.01M-139.9%
FY2023Dec 31, 2023$60.16M–
FY2022Dec 31, 2022-$79.88M–
FY2021Dec 31, 2021-$54.56M–
FY2020Dec 31, 2020-$49.35M–
FY2019Dec 31, 2019-$38.12M–
FY2018Dec 31, 2018-$28.32M–
FY2017Dec 31, 2017-$24.56M–
FY2016Dec 31, 2016-$29.35M–
FY2015Dec 31, 2015-$24.55M–
FY2014Dec 31, 2014-$9.47M–
FY2013Dec 31, 2013-$4.31M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$14.89M–
Q1 FY2026Mar 31, 2026-$8.10M–
Q4 FY2025Dec 31, 2025$18.40M–
Q3 FY2025Sep 30, 2025-$8.72M-1240.4%
Q2 FY2025Jun 30, 2025-$7.50M–
Q1 FY2025Mar 31, 2025-$7.47M–
Q4 FY2024Dec 31, 2024-$9.91M–
Q3 FY2024Sep 30, 2024$765.00K-93.8%
Q2 FY2024Jun 30, 2024-$10.86M-114.6%
Q1 FY2024Mar 31, 2024-$4.01M–
Q4 FY2023Dec 31, 2023-$7.74M–
Q3 FY2023Sep 30, 2023$12.42M–
Q2 FY2023Jun 30, 2023$74.40M–
Q1 FY2023Mar 31, 2023-$18.92M–
Q4 FY2022Dec 31, 2022-$22.81M–
Q3 FY2022Sep 30, 2022-$22.51M–
Q2 FY2022Jun 30, 2022-$18.58M–
Q1 FY2022Mar 31, 2022-$15.99M–
Q4 FY2021Dec 31, 2021-$25.52M–
Q3 FY2021Sep 30, 2021-$16.59M–
Q2 FY2021Jun 30, 2021-$11.70M–
Q1 FY2021Mar 31, 2021-$759.00K–
Q4 FY2020Dec 31, 2020-$16.57M–
Q3 FY2020Sep 30, 2020-$9.87M–
Q2 FY2020Jun 30, 2020-$8.86M–
Q1 FY2020Mar 31, 2020-$14.06M–
Q4 FY2019Dec 31, 2019-$13.46M–
Q3 FY2019Sep 30, 2019-$10.40M–
Q2 FY2019Jun 30, 2019-$7.76M–
Q1 FY2019Mar 31, 2019-$6.50M–
Q4 FY2018Dec 31, 2018-$6.06M–
Q3 FY2018Sep 30, 2018-$6.15M–
Q2 FY2018Jun 30, 2018-$7.90M–
Q1 FY2018Mar 31, 2018-$8.22M–
Q4 FY2017Dec 31, 2017-$5.16M–
Q3 FY2017Sep 30, 2017-$5.25M–
Q2 FY2017Jun 30, 2017-$7.38M–
Q1 FY2017Mar 31, 2017-$6.77M–
Q4 FY2016Dec 31, 2016-$4.55M–
Q3 FY2016Sep 30, 2016-$6.85M–

More Scynexis figures

See a number that looks wrong?